Dr. McCormick’s work clarifying how KRAS mutations alter RAS signaling helped lay the foundation for the first targeted therapies against this common cancer driver.
Category:Cover Story
Dr. Mardis is a trailblazer in developing next-generation sequencing technologies.
Dr. Winn recognized that improving care for all cancer patients means bringing translational research into at-risk rural and urban communities.
Dr. Dang was among the first to discover that MYC oncogenes regulate tumor metabolism.
The CAR T-cell pioneer developed breakthrough therapies for blood cancer patients. Now he has turned his attention to solid-tumor cancers.